2025
SJR Q1
JCR Q3 · 2,5
3 matched articles
ESCI
Journal detail
Neuro-Oncology Practice
- Publisher
- Oxford University Press
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
2054257720542585
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,95
- Quartile Q1
- H-Index 40
- Cites/doc 2,28
- Docs (3y) 243
- Cites (3y) 618
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,5
- 5Y JIF 3
- JCI 0,64
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q1
- Neurology Q2
- Oncology Q2
Areas
- Medicine
- Neuroscience
WoS categories
- Oncology | Clinical Neurology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q3 | 0,95 | 2,5 | 3 | 0,64 | Q2 | 40 |
| 2024 | Q2 | Q2 | 0,901 | 2,5 | 2,8 | 0,68 | Q2 | 34 |
| 2023 | Q2 | Q2 | 0,806 | 2,4 | 2,4 | 0,74 | Q2 | 34 |
| 2022 | Q2 | — | 0,769 | 2,7 | 2,8 | 0,73 | Q2 | 34 |
| 2021 | Q2 | — | 0,655 | — | — | 0,61 | Q3 | 34 |
| 2020 | Q2 | — | 0,666 | — | — | 0,55 | Q3 | 34 |
| 2019 | Q2 | — | 0,475 | — | — | — | — | 34 |
| 2017 | — | — | — | — | — | — | — | 34 |
| 2016 | — | — | — | — | — | — | — | 34 |
| 2015 | — | — | — | — | — | — | — | 34 |
| 2014 | — | — | — | — | — | — | — | 34 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | ESCI | Q3 | Q3 | 161/296 |
| 2025 | ONCOLOGY | ESCI | Q3 | Q2 | 204/333 |
| 2024 | CLINICAL NEUROLOGY | ESCI | Q2 | Q3 | 143/286 |
| 2024 | ONCOLOGY | ESCI | Q3 | Q2 | 188/328 |
| 2023 | CLINICAL NEUROLOGY | ESCI | Q2 | Q2 | 140/280 |
| 2022 | CLINICAL NEUROLOGY | ESCI | — | Q2 | — |
| 2021 | CLINICAL NEUROLOGY | ESCI | — | Q3 | — |
| 2020 | CLINICAL NEUROLOGY | ESCI | — | Q3 | — |